1,139 results on '"He, Qiaojun"'
Search Results
52. Protective effect of borneol on the cutaneous toxicity of gilteritinib
53. Author correction to ‘Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA’ [Acta Pharmaceutica Sinica B 13 (2023) 2585–2600]
54. Deubiquitinating enzyme JOSD2 affects susceptibility of non-small cell lung carcinoma cells to anti-cancer drugs through DNA damage repair
55. Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment
56. The Frontline of Alternatives to Animal Testing: Novel In vitro Skin Model Application in Drug Development and Evaluation
57. s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand–foot skin reaction that can be reversed by nicotinamide
58. STAT3 dictates β-cell apoptosis by modulating PTEN in streptozocin-induced hyperglycemia
59. High-mobility group box 1 protein-mediated necroptosis contributes to dasatinib-induced cardiotoxicity
60. Inhibition of PRKAA/AMPK (Ser485/491) phosphorylation by crizotinib induces cardiotoxicity via perturbing autophagosome-lysosome fusion.
61. KLF12 transcriptionally regulates PD‐L1 expression in non‐small cell lung cancer.
62. TransFoxMol: predicting molecular property with focused attention
63. Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13‐Mediated Stabilization of Bcl‐XL
64. An update on Alectinib: a first line treatment for ALK-positive advanced lung cancer
65. TEMPORARY REMOVAL: Crizotinib induces pulmonary toxicity by blocking autophagy flux in alveolar epithelial cells
66. DJ-1 as a Therapeutic Target Against Cancer
67. HMGB1 contributes to adriamycin-induced cardiotoxicity via up-regulating autophagy
68. Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2
69. Palmitoyltransferase ZDHHC21 regulates oxidative phosphorylation to induce differentiation block and stemness in AML
70. Targeting Labile Iron-Mediated Ferroptosis Provides a Potential Therapeutic Strategy for Rhabdomyolysis-Induced Acute Kidney Injury
71. Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
72. Supplementary Table S1 from All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages
73. Supplementary Table S1 from LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization
74. Supplementary Methods and Figure Legend from Bortezomib Sensitizes Human Acute Myeloid Leukemia Cells to All-Trans-Retinoic Acid–Induced Differentiation by Modifying the RARα/STAT1 Axis
75. Figure S3 from PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3
76. Supplementary Figure 4 from Bortezomib Sensitizes Human Acute Myeloid Leukemia Cells to All-Trans-Retinoic Acid–Induced Differentiation by Modifying the RARα/STAT1 Axis
77. Data from All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages
78. Supplementary Figure 3 from Bortezomib Sensitizes Human Acute Myeloid Leukemia Cells to All-Trans-Retinoic Acid–Induced Differentiation by Modifying the RARα/STAT1 Axis
79. Supplementary Figure 2 from Bortezomib Sensitizes Human Acute Myeloid Leukemia Cells to All-Trans-Retinoic Acid–Induced Differentiation by Modifying the RARα/STAT1 Axis
80. Supplementary Methods from PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3
81. Data from LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization
82. Supplementary figures S1-S6 from All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages
83. Supplementary Figures and Legends from LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization
84. Data from PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3
85. Supplementary Figure 1 from Bortezomib Sensitizes Human Acute Myeloid Leukemia Cells to All-Trans-Retinoic Acid–Induced Differentiation by Modifying the RARα/STAT1 Axis
86. AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells
87. The impact of lipids on the cancer–immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy
88. Table S1 from Hypoxia-Induced WSB1 Promotes the Metastatic Potential of Osteosarcoma Cells
89. Figure S1 from Hypoxia-Induced WSB1 Promotes the Metastatic Potential of Osteosarcoma Cells
90. Data from USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ
91. Supplemental Methods from Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis
92. Supplementary Data from USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ
93. Supplemental Tables from Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis
94. Support Information from Hypoxia-Induced WSB1 Promotes the Metastatic Potential of Osteosarcoma Cells
95. Data from Hypoxia-Induced WSB1 Promotes the Metastatic Potential of Osteosarcoma Cells
96. Supplemental Figures and Legends from Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis
97. Commentary: Deubiquitination complex platform: a plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes
98. The involvement of M2 macrophage polarization inhibition in fenretinide-mediated chemopreventive effects on colon cancer
99. DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase
100. Correction: Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.